Respiratory Infections News

Efforts by IDWeek’s program committee to ensure gender equity during the conference led to a more than 13 percentage-point increase in the proportion of speaker slots filled by women since 2013, according to an analysis.

Many countries are seeing a spike in COVID-19, including the United States, where a third wave has pushed the number of cases above 8.2 million, including 220,000 deaths.

In the spring, in anticipation that the COVID-19 pandemic could complicate IDWeek, organizers asked presenters to prerecord sessions in the event they could not travel.

The NIH announced the launch of an adaptive phase 3 clinical trial that will evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.

Like many other medical conferences, IDWeek was converted to a virtual meeting this year because of COVID-19.

Researchers found high rates of asymptomatic and presymptomatic SARS-CoV-2 infections in a multistate sample of skilled nursing facilities between March and July.

The United States had a mortality rate that was 20% higher than expected between March and July, and it experienced high COVID-19-related mortality and excess all-cause deaths into September, according to results from two JAMA studies.

The risk for adverse pregnancy outcomes is higher among women with HIV who initiate isoniazid preventive therapy for tuberculosis during pregnancy compared with those who initiate it after delivery, study data confirmed.

Lefamulin demonstrated high early clinical response and was safe in patients with community-acquired bacterial pneumonia with advanced age and comorbidities, according to a post hoc, pooled analysis of the LEAP 1 and LEAP 2 trials.

Observational data indicate that common coronaviruses are associated with worse outcomes among patients compared with influenza, according to a study that excluded SARS-CoV-2.